(@dongfang.liu)

Goal 3: Advance Translational Research

New treatment for HIV and HIV-related lymphoma

Highly active antiretroviral therapy (HAART), while clearly invaluable, does not halt growth or proliferation of HL, in fact, while AIDS-defining malignancies like Kaposi’s sarcoma (KS) and non-Hodgkin’s lymphoma (NHL) have declined thanks to HAART, the incidence of HL in HIV patients has actually increased, from 14 times higher than that of non-HIV patients in the pre-HAART era to 32 times higher in the HAART era. Typical ...more »

Voting

-26 net votes
8 up votes
34 down votes
Active
(@wheeze)

Goal 2: Reduce Human Disease

Sublingual Immunotherapy for Treatment of Asthma

As the current chair of the Research and Training Division, I would like to convey that the AAAAI membership would like the NHLBI to consider the following in the development of its strategic plan: What role should sublingual immunotherapy play in the treatment of asthma?


Voting

-9 net votes
5 up votes
14 down votes
Active
(@lholmber)

Goal 2: Reduce Human Disease

Can we safely move CAR therapy i beyond limited academic centers?

CAR therapy has resurrected the role of immunotherapy in treating cancer. But it has significant toxicity. Can we train , standardize the care of and adequately oversee the care of patients getting CAR therapy , especially as company begin to approach FDA for approval of this therapy and up scale for mass treatment.

Voting

11 net votes
26 up votes
15 down votes
Active